Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets,including one without an experimentally resolved structure

03-18

EZVIZ launches a special campaign to celebrate love and protection, ensuring that safety is never missed in any family moment

JAKARTA,Indonesia,March 18,2025-- EZVIZ,an unwavering protector for family with smart home gadgets,celebrates the holy month of Ramadan by launching its campaignthemed "Love\'s Guardian: A Haven

03-18

Global Times: What does 'whole-process' mean in China's democracy? A Shanghai practice

BEIJING,March 17,2025-- Since the publication of the first volume ofXi Jinping: The Governance of Chinain 2014,the book has garnered widespread recognition globally,becoming a key resource for politic

03-17

Businesses across Southeast Asia are engaging independent talent at rates ranging from USD 250 to USD 1600 per day to scale faster: Outsized's 2025 Talent-on-Demand Report reveals critical hiring trends and most in-demand skills

SINGAPORE,March 17,2025-- Companies across Southeast Asia are increasingly building teams and capabilities by integrating independent professionals across functions and levels. Skills in high demand i

03-17

Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025

Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington\'s Disease to members of the Huntington\'s Disease Youth Organization,at the annual HYDO Intern

03-17

CNOOC Limited Brings On-stream Two New Projects

HONG KONG,March 17,2025-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) today announces that Caofeidian 6-4 Oilfield Comprehensive Adjustment P

03-17

HanAll Biopharma Announces Orphan Drug Designation for Batoclimab in Japan for Active Thyroid Eye Disease

Batoclimab receives Orphan Drug Designation in Japan,advancing treatment for active Thyroid Eye Disease (TED).

03-17

Autoliv: Board of Directors approves renewal of EMTN Programme

STOCKHOLM,March 15,2025-- The Audit and Risk Committee of the Board of Directors ofAutoliv,Inc. (NYSE: ALV) (SSE: ALIVsdb) (the "Company") approved on March 12,2025 the renewal for one year

03-17

"Daily Get·Lottery fund trust services (formerly Cola Financial) and มิราเคิล กรุ๊ป จำกัด reached a strategic cooperation in lottery fund trust to jointly usher in a new era of sunshine in the Asia-Pacific lottery market"

03-17

Singapore's LeVeL33 Recognized by Guinness World Records as World's Highest Microbrewery in a Building

149.32m-HighContemBrewery ExperienceSets Global Benchmark in Craftsmanship and Sustainability SINGAPORE,March 13,2025-- On March 12,LeVeL33was awarded the title of Highest Microbrewery in a Building

03-15